Grifols, FTC Ink Deal To Allow $3.4B Talecris Tie-Up
Grifols SA said Monday it had reached a tentative agreement with federal antitrust regulators that should allow its planned $3.4 billion purchase of rival Talecris Biotherapeutics Holdings Corp. to move forward...To view the full article, register now.
Already a subscriber? Click here to view full article